These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33413678)

  • 21. Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells.
    Li H; Rong P; Ma X; Nie W; Chen Y; Zhang J; Dong Q; Yang M; Wang W
    J Diabetes Res; 2020; 2020():3847171. PubMed ID: 32455132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy.
    Liu Q; Lv S; Liu J; Liu S; Wang Y; Liu G
    Diabetes Res Clin Pract; 2020 Apr; 162():108093. PubMed ID: 32109518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal Stromal Cells Derived Conditioned Medium in Pulmonary Fibrosis: A Systematic Review and Meta-analysis.
    Ali KM; Fattah FHR; Omar SH; Gubari MIM; Yousefifard M; Hosseini M
    Arch Iran Med; 2020 Dec; 23(12):870-879. PubMed ID: 33356346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow mesenchymal stem cells ameliorated kidney fibrosis by attenuating TLR4/NF-κB in diabetic rats.
    Lin L; Lin H; Wang D; Bao Z; Cai H; Zhang X
    Life Sci; 2020 Dec; 262():118385. PubMed ID: 32926926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentoxifylline for diabetic kidney disease.
    Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model.
    He J; Wang Y; Sun S; Yu M; Wang C; Pei X; Zhu B; Wu J; Zhao W
    Nephrology (Carlton); 2012 Jul; 17(5):493-500. PubMed ID: 22369283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traditional Chinese medicine for the treatment of diabetic kidney disease: A study-level pooled analysis of 44 randomized controlled trials.
    Liu X; Ge M; Zhai X; Xiao Y; Zhang Y; Xu Z; Zhou Z; Mei Z; Yang X
    Front Pharmacol; 2022; 13():1009571. PubMed ID: 36313382
    [No Abstract]   [Full Text] [Related]  

  • 28. Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies.
    Li DY; Li RF; Sun DX; Pu DD; Zhang YH
    Stem Cell Res Ther; 2021 Aug; 12(1):461. PubMed ID: 34407861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regenerative Potential of Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis and Chondral Defects: A Systematic Review and Meta-analysis.
    Maheshwer B; Polce EM; Paul K; Williams BT; Wolfson TS; Yanke A; Verma NN; Cole BJ; Chahla J
    Arthroscopy; 2021 Jan; 37(1):362-378. PubMed ID: 32497658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model.
    Semedo P; Correa-Costa M; Antonio Cenedeze M; Maria Avancini Costa Malheiros D; Antonia dos Reis M; Shimizu MH; Seguro AC; Pacheco-Silva A; Saraiva Camara NO
    Stem Cells; 2009 Dec; 27(12):3063-73. PubMed ID: 19750536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action.
    Park JH; Hwang I; Hwang SH; Han H; Ha H
    Diabetes Res Clin Pract; 2012 Dec; 98(3):465-73. PubMed ID: 23026513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Promise of Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease.
    Griffin TP; Martin WP; Islam N; O'Brien T; Griffin MD
    Curr Diab Rep; 2016 May; 16(5):42. PubMed ID: 27007719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy.
    Grange C; Tritta S; Tapparo M; Cedrino M; Tetta C; Camussi G; Brizzi MF
    Sci Rep; 2019 Mar; 9(1):4468. PubMed ID: 30872726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell RNA transcriptomic reveal the mechanism of MSC derived small extracellular vesicles against DKD fibrosis.
    Ji C; Zhang J; Shi H; Chen B; Xu W; Jin J; Qian H
    J Nanobiotechnology; 2024 Jun; 22(1):339. PubMed ID: 38890734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant and Anti-Inflammatory Properties of Hydroxyl Safflower Yellow a in Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials.
    Fu S; Zhou Q; Gao Y; Yang Y; Chen H; Yuan L; Li Z; Chen Q
    Front Pharmacol; 2022; 13():929169. PubMed ID: 36034830
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic effects of Yiqi Huoxue prescription on diabetic nephropathy: a meta-analysis and systematic review.
    Ye C; Gu L; Feng Y; Zhou F; She W
    Ann Palliat Med; 2021 Jun; 10(6):6617-6629. PubMed ID: 34154340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of MSC-derived small extracellular vesicles in treating type II diabetic cutaneous wounds: a systematic review and meta-analysis of animal models.
    Yue G; Li Y; Liu Z; Yu S; Cao Y; Wang X
    Front Endocrinol (Lausanne); 2024; 15():1375632. PubMed ID: 39076515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
    Bai Y; Wang J; He Z; Yang M; Li L; Jiang H
    Med Sci Monit; 2019 Apr; 25():3069-3076. PubMed ID: 31023998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical Evidence for the Effectiveness of Mesenchymal Stromal Cells for Diabetic Cardiomyopathy: A Systematic Review and Meta-analysis.
    Liu B; Zhang J; Zhou Z; Feng B; He J; Yan W; Zhou X; Amponsah AE; Guo R; Du X; Liu X; Cui H; O'Brien T; Ma J
    Curr Stem Cell Res Ther; 2024; 19(2):220-233. PubMed ID: 37165495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.